Cargando…

Δ(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles

BACKGROUND: Immunomodulatory effects in humans of Δ(9−)Tetrahydrocannabinol (THC), the psychoactive component of marijuana are controversial. Tissue factor (TF), the activator of the extrinsic coagulation cascade, is increased on circulating activated monocytes and is expressed on microvesicles rele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Julie C., Klein, Thomas W., Goldberger, Bruce A., Sleasman, John W., Mackman, Nigel, Goodenow, Maureen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469459/ https://www.ncbi.nlm.nih.gov/pubmed/26085816 http://dx.doi.org/10.1186/s12950-015-0084-1

Ejemplares similares

Acute human exposure assessment to tetrahydrocannabinol (Δ(9)‐THC)
por: Arcella, Davide, et al.
Publicado: (2020)

Genetic Modulation of Initial Sensitivity to Δ9-Tetrahydrocannabinol (THC) Among the BXD Family of Mice
por: Parks, Cory, et al.
Publicado: (2021)

Default Mode Network in the Effects of Δ9-Tetrahydrocannabinol (THC) on Human Executive Function
por: Bossong, Matthijs G., et al.
Publicado: (2013)

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
por: Poyatos, Lourdes, et al.
Publicado: (2020)

The Effect of Orally Administered Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Obesity Parameters in Mice
por: Eitan, Adi, et al.
Publicado: (2023)

Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
por: Boonyayothin, Wanuttha, et al.
Publicado: (2022)

Monocyte Tissue Factor Expression: Lipopolysaccharide Induction and Roles in Pathological Activation of Coagulation
por: Sachetto, Ana T. A., et al.
Publicado: (2023)

Δ(9)-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial
por: Adam, Kirsten C. S., et al.
Publicado: (2020)

Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro
por: Medveczky, Maria M, et al.
Publicado: (2004)

Indeterminacy of cannabis impairment and ∆(9)-tetrahydrocannabinol (∆(9)-THC) levels in blood and breath
por: Wurz, Gregory T., et al.
Publicado: (2022)

Sex differences in acute delta-9-tetrahydrocannabinol (Δ(9)-THC) response and tolerance as a function of mouse strain
por: Lulek, Courtney F., et al.
Publicado: (2023)

A Critical Review of the Role of the Cannabinoid Compounds Δ(9)-Tetrahydrocannabinol (Δ(9)-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment
por: Jones, Éamon, et al.
Publicado: (2020)

Chronic low-dose Δ(9)-tetrahydrocannabinol (THC) treatment stabilizes dendritic spines in 18-month-old mice
por: Komorowska-Müller, Joanna Agnieszka, et al.
Publicado: (2023)

Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imaging
por: Gilman, Jodi M., et al.
Publicado: (2022)

CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ(9)-Tetrahydrocannabinol (Δ(9)-THC)-Induced Aversive Effects in Mice
por: Han, Xiao, et al.
Publicado: (2017)

A Single δ(9)-Tetrahydrocannabinol (THC) Dose During Brain Development Affects Markers of Neurotrophy, Oxidative Stress, and Apoptosis
por: Philippot, Gaëtan, et al.
Publicado: (2019)

Hormonal status and age differentially affect tolerance to the disruptive effects of delta-9-tetrahydrocannabinol (Δ(9)-THC) on learning in female rats
por: Winsauer, Peter J., et al.
Publicado: (2015)

Continuous-Flow Synthesis of Δ(9)-Tetrahydrocannabinol and Δ(8)-Tetrahydrocannabinol from Cannabidiol
por: Bassetti, Benedetta, et al.
Publicado: (2023)

Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
por: Lachenmeier, Dirk W., et al.
Publicado: (2023)

Glucocorticoids, Stress and Delta-9 Tetrahydrocannabinol (THC) during Early Embryonic Development
por: Kuzma-Hunt, Alexander G., et al.
Publicado: (2021)

Effects of Delta-9 Tetrahydrocannabinol (THC) on Oocyte Competence and Early Embryonic Development
por: Misner, Megan J., et al.
Publicado: (2021)

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
por: Hutten, Nadia R. P. W., et al.
Publicado: (2022)

Quantitative analysis of performance on a progressive-ratio schedule: effects of reinforcer type, food deprivation and acute treatment with Δ(9)-tetrahydrocannabinol (THC)
por: Olarte-Sánchez, C.M., et al.
Publicado: (2015)

Multi-laboratory validation of a Δ9-tetrahydrocannabinol LC-MS/MS test kit designed for quantifying THC and marijuana metabolites in blood
por: Patton, Amy L, et al.
Publicado: (2018)

Administration of Δ9‐Tetrahydrocannabinol (THC) Post‐Staphylococcal Enterotoxin B Exposure Protects Mice From Acute Respiratory Distress Syndrome and Toxicity
por: Mohammed, Amira, et al.
Publicado: (2020)

Study of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extraction FROM dried oral fluid spots (DOFS) and LC–MS/MS detection
por: Gorziza, Roberta, et al.
Publicado: (2021)

A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆(9)-tetrahydrocannabinol (THC) by vaporisation
por: Solowij, Nadia, et al.
Publicado: (2014)

Deleterious Effects of Ethanol, Δ(9)-Tetrahydrocannabinol (THC), and Their Combination on the Spatial Memory and Cognitive Flexibility in Adolescent and Adult Male Rats in the Barnes Maze Task
por: Gibula-Tarlowska, Ewa, et al.
Publicado: (2020)

Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination
por: Linher-Melville, Katja, et al.
Publicado: (2020)

Efficacy of Δ(9) -Tetrahydrocannabinol (THC) Alone or in Combination With a 1:1 Ratio of Cannabidiol (CBD) in Reversing the Spatial Learning Deficits in Old Mice
por: Nidadavolu, Prakash, et al.
Publicado: (2021)

Δ(9)-tetrahydrocannabinol discrimination: Effects of route of administration in mice
por: Marusich, Julie A., et al.
Publicado: (2023)

Toxicological Properties of Δ(9)-tetrahydrocannabinol and Cannabidiol
por: Černe, Katarina
Publicado: (2020)

MON-010 Effects of Delta-9-Tetrahydrocannabinol (THC) on Oocyte Competence and Early Embryonic Development
por: Misner, Megan, et al.
Publicado: (2020)

Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
por: Brown, Joshua D.
Publicado: (2020)

The Diels‐Alder Approach towards Cannabinoid Derivatives and Formal Synthesis of Tetrahydrocannabinol (THC)
por: Hurrle, Thomas, et al.
Publicado: (2021)

Multiple Sclerosis Treatments Affect Monocyte-Derived Microvesicle Production
por: Blonda, Maria, et al.
Publicado: (2017)

Different Contribution of Monocyte- and Platelet-Derived Microvesicles to Endothelial Behavior
por: Brambilla, Marta, et al.
Publicado: (2022)

Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
por: Golombek, Patricia, et al.
Publicado: (2020)

Biomechanical Effects of Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD), the Major Constituents of Cannabis, in a Sprague Dawley Rat Achilles Tendon Surgical Repair Model
por: Stauch, Chris M., et al.
Publicado: (2020)

Pilot clinical and pharmacokinetic study of Δ(9)-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain
por: Clarke, Stephen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6jl5pst1cffi4blsjbicf95fk1